CD40 ligand deficiency: neurologic sequelae with radiographic correlation

Area of Science:

• Immunology
• Neuroscience
• Infectious Diseases

Background:

• CD40 ligand deficiency increases susceptibility to central nervous system (CNS) infections.
• Detailed reports on the neurologic progression and long-term outcomes of CNS complications in these patients are lacking.
• Characterizing CNS complications in primary immune deficiencies aids in identifying novel pathogens.

Observation:

• Five patients with CD40 ligand deficiency and neurodegeneration were identified from a cohort of 31.
• These patients exhibited progressive neurologic and cognitive decline without acute encephalitis.
• Anatomic brain abnormalities and high mortality (60%) were observed.

Findings:

• No pathogens were identified in four patients receiving intravenous immunoglobulin therapy.
• The clinical presentation resembles chronic enteroviral encephalitis seen in X-linked agammaglobulinemia.
• The exact cause remains undetermined, possibly involving subtherapeutic IgG levels or impaired antiviral responses.

Implications:

• Emerging gene-chip technologies may identify unknown viruses in primary immune deficiencies.
• Prospective neurocognitive evaluations could aid in early identification of affected patients.
• Understanding these CNS complications is crucial for improving patient outcomes and diagnostic strategies.